BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36545328)

  • 1. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
    Sahlander F; Bensing S; Falhammar H
    Front Endocrinol (Lausanne); 2022; 13():1017303. PubMed ID: 36545328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
    Wagnerova H; Lazúrová I; Habalová V; Dudásová D; Vrzgula A
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in hormonal levels between heterozygous
    Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
    Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?
    Falhammar H
    Endocrine; 2014 Sep; 47(1):308-14. PubMed ID: 24452876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).
    Koren I; Weintrob N; Kebesch R; Majdoub H; Stein N; Naor S; Segev-Becker A
    J Clin Endocrinol Metab; 2024 Feb; 109(3):852-857. PubMed ID: 37715965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the 21-hydroxylase deficiency and the adrenal functions in young females with Turner syndrome.
    Onder A; Aycan Z; Cetinkaya S; Kendirci HN; Bas VN; Agladioglu SY
    J Pediatr Endocrinol Metab; 2012; 25(7-8):681-5. PubMed ID: 23155693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
    Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY PRESENTING AS ADRENAL INCIDENTALOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Falhammar H; Torpy DJ
    Endocr Pract; 2016 Jun; 22(6):736-52. PubMed ID: 26919651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
    Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T; Schlaghecke R
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.
    Kiedrowicz B; Binczak-Kuleta A; Lubikowski J; Koziolek M; Andrysiak-Mamos E; Ostanek-Panka M; Ciechanowicz A; Syrenicz A
    Horm Metab Res; 2015 Aug; 47(9):662-7. PubMed ID: 25970792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency.
    Liu E; Luo H; Zhou K; Zhang Y
    Arch Gynecol Obstet; 2023 Sep; 308(3):871-882. PubMed ID: 36773044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kang MJ; Kim SM; Lee YA; Shin CH; Yang SW
    J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG; Bayraktar F; Yilmaz C
    Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
    Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
    J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.